High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy

These novel findings suggest that the HMGB1 system could be targeted to prevent seizure generation and may provide clinically useful prognostic biomarkers which may also predict the patient's response to therapy.